Table 3.
Reference values of the various tests carried out
| Tests | Reference ranges |
|---|---|
| Prolactin (mIU/l) | 102–496 |
| Cortisol (nmol/l) | 198–720 |
| ACTH (ng/l) | 0000 h <15; 0900 h <46 |
| Serum osmolality (mmol/kg) | 275–295 |
| Urine osmolality (mOsmol/kg) | 100–800 |
| Serum sodium (mmol/l) | 133–144 |
| HbA1c (mmol/mol) | 19–48 |
| Random glucose (mmol/l) | <11.1 |
| ACE (IU/l) | 12–68 |
| Follicular phase | |
| FSH (IU/l) | 3.5–13.0 |
| LH (IU/l) | 2.4–13.0 |
| Oestradiol (pmol/l) | 46–607 |
| Ovulation phase | |
| FSH (IU/l) | 4.7–22.0 |
| LH (IU/l) | 14.0–96.0 |
| Oestradiol (pmol/l) | 315–1828 |
| Luteal phase | |
| FSH (IU/l) | 1.7–7.7 |
| LH (IU/l) | 1.0–11.0 |
| Oestradiol (pmol/l) | 161–774 |
| Post-menopausal | |
| FSH (IU/l) | 26–135 |
| LH (IU/l) | 7.7–59 |
| Oestradiol (pmol/l) | 18.4–201 |
| Patient 1 | |
| TSH (IU/l) | 0.5–3.6 |
| FT4 (pmol/l) | 10.0–16.9 |
| FT3 (pmol/l) | 3.4–6.5 |
| IGF1 (μg/ml) | 284–713 |
| Patient 2 | |
| TSH (IU/l) | 0.27–4.2 |
| FT4 (pmol/l) | 12.0–22.0 |
| FT3 (pmol/l) | 3.1–6.8 |
| IGF1 (μg/ml) | 115–340 |
| Patient 3 | |
| TSH (IU/l) | 0.35–4.5 |
| FT4 (pmol/l) | 10.3–21.9 |
| FT3 (pmol/l) | 3.1–6.8 |
| IGF1 (μg/ml) | 52–227 |
This work is licensed under a